NAAA
PFE icon

New Age Alpha Advisors’s Pfizer PFE Stock Holding History

New Age Alpha Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Sell
117,185
-1,510
-1% -$39.5K 0.12% 223
2026
Q1 		$3.33M Buy
118,695
+100,794
+563% +$2.68M 0.16% 190
2025
Q4 		$446K Buy
+17,901
New +$451K 0.02% 495

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New Age Alpha Advisors's PFE Position: Q2 2026 in Review

New Age Alpha Advisors reduced its Pfizer (PFE) stake by 1.3% in Q2 2026, selling an estimated $39.5K and leaving 117,185 shares worth $2.82M. The position accounts for 0.12% of the portfolio, ranked #223.

New Age Alpha Advisors first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $3.33M in Q1 2026. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • New Age Alpha Advisors held 117,185 shares of Pfizer worth $2.82M as of Q2 2026.
  • New Age Alpha Advisors sold 1,510 Pfizer shares in Q2 2026, an estimated $39.5K.
  • Pfizer made up 0.12% of New Age Alpha Advisors's portfolio in Q2 2026, its #223 holding.
  • New Age Alpha Advisors first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • New Age Alpha Advisors's Pfizer position peaked at $3.33M in Q1 2026.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on New Age Alpha Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.